Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Hemoperfusion--state of art

M Spighi1, S Faenza, M Fini

  • 1Institute of Anaesthesiology and Resuscitation, University of Bologna.

Bollettino Della Societa Italiana Di Biologia Sperimentale
|November 1, 1993
PubMed
Summary

Selective hemoperfusion (HP) utilizes specific sorbents for targeted toxin removal, offering potent therapeutic potential. This approach is currently underutilized despite its proven efficacy in various medical applications.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Acute promyelocytic leukemias share cooperative mutations with other myeloid-leukemia subgroups.

Blood cancer journal·2013
Same author

Filgrastim XM02 (Tevagrastim®) after autologous stem cell transplantation compared to lenograstim: favourable cost-efficacy analysis.

Ecancermedicalscience·2013
Same author

Experimental demonstration of modulation instability in an optical fiber with a periodic dispersion landscape.

Optics letters·2012
Same author

Prediction of outcomes in patients with Ph+ chronic myeloid leukemia in chronic phase treated with nilotinib after imatinib resistance/intolerance.

Leukemia·2012
Same author

BCR-ABL-specific cytotoxic T cells in the bone marrow of patients with Ph(+) acute lymphoblastic leukemia during second-generation tyrosine-kinase inhibitor therapy.

Blood cancer journal·2012
Same author

Application of the whole-transcriptome shotgun sequencing approach to the study of Philadelphia-positive acute lymphoblastic leukemia.

Blood cancer journal·2012

Area of Science:

  • Biomedical Engineering
  • Nephrology
  • Immunology

Background:

  • Hemoperfusion (HP) has evolved from general toxin removal to specialized applications.
  • The development of specific and selective sorbents is crucial for targeted therapeutic interventions.

Purpose of the Study:

  • To review the state-of-the-art in hemoperfusion, focusing on selective sorbent development.
  • To explore HP applications in immunology, critical care, and uremia.
  • To present experimental studies using coated anion exchange resins for various medical conditions.

Main Methods:

  • Review of existing literature on hemoperfusion and sorbent technology.
  • Experimental application of coated anion exchange resins in treating acute respiratory insufficiency, metabolic alkalosis, and managing antiblastic agents.

Related Experiment Videos

  • Development of specialized resins for phosphate removal in uremic patients.

    • Main Results:

    • Demonstrated efficacy of hemoperfusion with coated anion exchange resins in diverse clinical scenarios.
    • Highlighted the importance of selective ion exchange over non-specific removal.
    • Investigated heparin subtraction and phosphate removal using tailored resin compositions.

    Conclusions:

    • Selective hemoperfusion is a powerful, yet underutilized, therapeutic modality.
    • The chemical properties of resins significantly influence their ion-binding capacity.
    • Future research should focus on expanding the application of selective hemoperfusion techniques.